World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
133
Citations
90110
World Ranking
2181
National Ranking
59

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Bertrand Coiffier is affiliated with the Centre Hospitalier Lyon Sud in France. Their research primarily focuses on the field of Medicine, with specific attention to subfields such as Pathology and Forensic Medicine, Cancer Research, Dermatology, and Immunology.

Their published work covers several main topics, including:

  • Lymphoma Diagnosis and Treatment
  • Genetic factors in colorectal cancer
  • Breast Cancer Treatment Studies
  • Cutaneous lymphoproliferative disorders research
  • T-cell and Retrovirus Studies

Recent publications include:

  • Resources-Stratified Guidelines for Classical Hodgkin Lymphoma (2020), published in the International Journal of Environmental Research and Public Health
  • Current Treatment of Peripheral T-cell Lymphoma (2022), published in ONCOLOGY

Frequent co-authors collaborating with Coiffier are:

  • Allan Relecom
  • Massimo Federico
  • Joseph M. Connors
  • Irène Biasoli
  • Alden A. Moccia

Coiffier's publications have appeared predominantly in the following venues:

  • International Journal of Environmental Research and Public Health
  • ONCOLOGY

Best Publications

  • CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Bertrand Coiffier;Eric Lepage;Josette Briere;Raoul Herbrecht

  • A predictive model for aggressive non-Hodgkin's lymphoma

    M. A. Shipp;D. P. Harrington;J. R. Anderson;J. O. Armitage

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    James O. Armitage

  • Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

    T Philip;C Guglielmi;A Hagenbeek;R Somers

  • Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.

    Richard R. Furman;Jeff P. Sharman;Steven E. Coutre;Bruce D. Cheson

  • Follicular lymphoma international prognostic index.

    Philippe Solal-Céligny;Pascal Roy;Philippe Colombat;Josephine White

  • Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    P Feugier;A. Van Hoof;C. Sebban;P. Solal-Celigny

  • Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

    Bertrand Coiffier;Catherine Thieblemont;Eric Van Den Neste;Gérard Lepeu

  • Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

    B. Coiffier;C. Haioun;N. Ketterer;A. Engert

  • Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

    Gilles Salles;John Francis Seymour;Fritz Offner;Armando Lopez-Guillermo

  • Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

    Bertrand Coiffier;Arnold Altman;Ching-Hon Pui;Anas Younes

  • Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

    Georg Hess;Raoul Herbrecht;Jorge Romaguera;Gregor Verhoef

  • Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma

    A Rohatiner;F d'Amore;B Coiffier;D Crowther

  • Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

    Nicolas Mounier;Josette Briere;Christian Gisselbrecht;Jean-Francois Emile

  • Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

    Bertrand Coiffier;Barbara Pro;H. Miles Prince;Francine Foss

  • European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

    James M. Foran;Ama Z. S. Rohatiner;David Cunningham;Razvan A. Popescu

  • Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

    Owen A. O'Connor;Barbara Pro;Lauren Pinter-Brown;Nancy Bartlett

  • Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas

    Christian Gisselbrecht;Philippe Gaulard;Eric Lepage;Bertrand Coiffier

Frequent Co-Authors

Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Hervé Tilly
Hervé Tilly Grenoble Alpes University
Corinne Haioun
Corinne Haioun Paris-Est Créteil University
Christian Gisselbrecht
Christian Gisselbrecht Université Paris Cité
Olivier Casasnovas
Olivier Casasnovas Grenoble Alpes University
Philippe Gaulard
Philippe Gaulard Université Paris Cité
Pier Luigi Zinzani
Pier Luigi Zinzani University of Bologna
Raoul Herbrecht
Raoul Herbrecht University of Strasbourg
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Jacques Bienvenu
Jacques Bienvenu Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens many pathways—both clinical and non-clinical—that can also be pursued online. Aspiring nurses can fast-track their careers with rn to np bridge programs, which allow registered nurses to become nurse practitioners with flexible, advanced coursework.

Those interested in promoting wellness beyond direct patient care might consider nutrition. Pursuing the best online food science degree can lead to roles in healthcare, food safety, or research—fields continually growing in demand.

Healthcare administration is another promising option. With top cahme-accredited mha programs available online, students can develop advanced leadership skills and prepare for management roles in hospitals, clinics, or public health organizations.

For registered nurses looking to continue patient care without additional in-person requirements, enrolling in an rn to bsn without clinicals program can offer a convenient path to advancing their qualifications and leadership opportunities.

Whether focusing on clinical excellence, management, or wellness, online degrees provide flexibility and specialization, helping students achieve diverse and rewarding careers in healthcare.

Best Scientists Citing Bertrand Coiffier

Trending Scientists